Suppr超能文献

脂肪酸氧化障碍患者的临床和生化监测。

Clinical and biochemical monitoring of patients with fatty acid oxidation disorders.

机构信息

Department of Clinical Genetics, Juliane Marie Centre, Copenhagen University Hospital, Copenhagen, Denmark.

出版信息

J Inherit Metab Dis. 2010 Oct;33(5):495-500. doi: 10.1007/s10545-009-9000-2. Epub 2010 Jan 12.

Abstract

Evidence-based guidelines for monitoring patients with disorders in fatty acid oxidation (FAO) are lacking, and most protocols are based on expert statements. Here, we describe our protocol for Danish patients. Clinical monitoring is the most important measure and has the main aims of checking growth, development and diet and of bringing families to the clinic regularly to remind them of their child's risk and review how they cope and adjust, e.g. to an acute intercurrent illness. Most of these measures are simple and can be carried out during a routine out-patient visit; we seldom do more complicated assessments by a neuropsychologist, speech therapist, or physical and occupational therapists. Paraclinical measurements are not used for short-chain and medium-chain disorders; electrocardiography (including 24 h monitoring) and echocardiography are done for most patients with long-chain and carnitine transporter deficiencies. Eye examination is done in all, and liver ultrasonography in some patients with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase/tri-functional protein (LCHAD/TFP) deficiencies. Biochemical follow-up includes determination of free carnitine and acylcarnitines. Free carnitine is measured to monitor carnitine supplementation in patients with multiple acyl-coenzyme A dehydrogenase deficiency (MADD) and carnitine transporter deficiency (CTD) and to follow metabolic control and disclose deficiency states in other FAO disorders. We are evaluating long-chain acylcarnitines in patients with long-chain disorders; so far there does not seem to be any clear-cut benefit in following these levels. An erythrocyte fatty acid profile is done in patients with long-chain disorders to test for essential fatty acid and docosahexanoic acid (DHA) deficiencies. The measurement of creatine kinase is helpful in long-chain disorders. Ongoing follow-up and education of the patient is important throughout life to prevent disease morbidity or death from metabolic crises.

摘要

缺乏监测脂肪酸氧化(FAO)障碍患者的循证指南,大多数方案都是基于专家意见制定的。在这里,我们描述丹麦患者的方案。临床监测是最重要的措施,主要目的是检查生长、发育和饮食情况,并定期让患者家属到诊所就诊,提醒他们孩子的风险,并评估他们的应对和调整情况,例如应对急性并发疾病。这些措施大多简单易行,可以在常规门诊就诊时进行;我们很少由神经心理学家、言语治疗师或物理治疗师和职业治疗师进行更复杂的评估。短链和中链疾病不进行临床测量;心电图(包括 24 小时监测)和超声心动图用于大多数长链和肉碱转运蛋白缺陷患者。所有患者都进行眼部检查,一些长链 3-羟酰基辅酶 A 脱氢酶/三功能蛋白(LCHAD/TFP)缺陷患者进行肝脏超声检查。生化随访包括游离肉碱和酰基肉碱的测定。游离肉碱的测定用于监测多种酰基辅酶 A 脱氢酶缺陷(MADD)和肉碱转运蛋白缺陷(CTD)患者的肉碱补充情况,以跟踪代谢控制情况,并发现其他 FAO 障碍中的缺乏状态。我们正在评估长链疾病患者的长链酰基肉碱水平;到目前为止,跟踪这些水平似乎没有任何明显的好处。长链疾病患者进行红细胞脂肪酸谱检查,以测试必需脂肪酸和二十二碳六烯酸(DHA)缺乏情况。肌酸激酶的测定对长链疾病有帮助。在整个生命周期中,对患者进行持续的随访和教育对于预防代谢危机导致的疾病发病率或死亡至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验